InvestorsHub Logo
Followers 74
Posts 10294
Boards Moderated 1
Alias Born 11/22/2004

Re: SkeBallLarry post# 16831

Monday, 10/14/2013 8:58:30 AM

Monday, October 14, 2013 8:58:30 AM

Post# of 429049
From that article: "Upsides: Should the panel be split, a trading range of $6-8 is likely until PDFUA, assuming FDA will favor the approval.

If the panel votes favorably, the stock easily doubles if not triples heading into the PDFUA date. Label language may also be an area of flexibility. I maintain a $28-32 level on the stock, if approved."

Tough to be in this, but if those prices ranges ever happen, who would want to be on the sideline?

In the first scenario that is a 20% to 60% increase.
In the second scenario that is a 500% increase.

Not bad!

I am NOT pumping this at all or bashing it, I am just reflecting on the numbers and the "potential" gains, based on the article.



Rayank

Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent AMRN News